Author

Alexander V. Kabanov

Professor, University of North Carolina Chapel Hill - Cited by 48,947 - Drug delivery - nanomedicine - polymers - biomaterials - bioengineering

Biography

Alexander V. Kabanov is affiliated to Center for Drug Delivery and Nanomedicine, University of Nebraska Medical Center. He is a recipient of many awards and grants for his valuable contributions and discoveries in major area of subject research. His international experience includes various programs, contributions and participation in different countries for diverse fields of study.  His research interests reflect in his wide range of publications in various national and international journals.  
Title
Cited by
Year
Bacteria boost mammalian host NAD metabolism by engaging the deamidated biosynthesis pathway
I Shats, JG Williams, J Liu, MV Makarov, X Wu, FB Lih, LJ Deterding, ...Cell metabolism 31 (3), 564-579. e7, 2020202
119
2020
Macrophage-derived extracellular vesicles as drug delivery systems for triple negative breast cancer (TNBC) therapy
MJ Haney, Y Zhao, YS Jin, SM Li, JR Bago, NL Klyachko, AV Kabanov, ...Journal of Neuroimmune Pharmacology 15, 487-500, 2020202
118
2020
A reanalysis of nanoparticle tumor delivery using classical pharmacokinetic metrics
LSL Price, ST Stern, AM Deal, AV Kabanov, WC ZamboniScience advances 6 (29), eaay9249, 2020202
67
2020
High-capacity poly (2-oxazoline) formulation of TLR 7/8 agonist extends survival in a chemo-insensitive, metastatic model of lung adenocarcinoma
N Vinod, D Hwang, SH Azam, AED Van Swearingen, E Wayne, ...Science advances 6 (25), eaba5542, 2020202
46
2020
Poly (2-oxazoline) nanoparticle delivery enhances the therapeutic potential of vismodegib for medulloblastoma by improving CNS pharmacokinetics and reducing systemic toxicity
D Hwang, T Dismuke, A Tikunov, EP Rosen, JR Kagel, JD Ramsey, C Lim, ...Nanomedicine: Nanotechnology, Biology and Medicine 32, 102345, 2021202
36
2021
Drug‐Dependent Morphological Transitions in Spherical and Worm‐Like Polymeric Micelles Define Stability and Pharmacological Performance of Micellar Drugs
C Lim, JD Ramsey, D Hwang, SCM Teixeira, CD Poon, JD Strauss, ...Small 18 (4), 2103552, 2022202
27
2022
Catalysis by enzymes entrapped in hydrated surfactant aggregates having various structures in organic solvents
NL Klyachko, AV Levashov, AV Kabanov, YL Khmelnitsky, K MartinekKinetics and catalysis in microheterogeneous systems, 135-182, 2020202
23
2020
A mechanism‐based pharmacokinetic model of remdesivir leveraging interspecies scaling to simulate COVID‐19 treatment in humans
PO Hanafin, B Jermain, AJ Hickey, AV Kabanov, ADM Kashuba, ...CPT: pharmacometrics & systems pharmacology 10 (2), 89-99, 2021202
23
2021
Nanoformulated SOD1 ameliorates the combined NASH and alcohol-associated liver disease partly via regulating CYP2E1 expression in adipose tissue and liver
T Gopal, N Kumar, C Perriotte-Olson, CA Casey, TM Donohue Jr, ...American Journal of Physiology-Gastrointestinal and Liver Physiology 318 (3 …, 2020202
19
2020
Non-heating alternating magnetic field nanomechanical stimulation of biomolecule structures via magnetic nanoparticles as the basis for future low-toxic biomedical applications
YI Golovin, DY Golovin, KY Vlasova, MM Veselov, AD Usvaliev, ...Nanomaterials 11 (9), 2255, 2021202
17
2021
Bioequivalence assessment of high-capacity polymeric micelle nanoformulation of paclitaxel and Abraxane® in rodent and non-human primate models using a stable isotope tracer assay
D Hwang, N Vinod, SL Skoczen, JD Ramsey, KS Snapp, SA Montgomery, ...Biomaterials 278, 1210, 2021202
14
2021
Genetically modified macrophages accomplish targeted gene delivery to the inflamed brain in transgenic Parkin Q311X (A) mice: importance of administration routes
Genetically modified macrophages accomplish targeted gene delivery to the inflamed brain in transgenic Parkin Q3X (A) mice: importance of administration routesMJ Haney, Y Zhao, J Fay, H Duhyeong, M Wang, H Wang, Z Li, YZ Lee, ...Scientific Reports 10 (1), 818, 2020202
11
2020
New advances in biomedical application of polymeric micelles
A Figueiras, C Domingues, I Jarak, AI Santos, A Parra, A Pais, ...Pharmaceutics 14 (8), 1700, 2022202
10
2022
Enhancing CDK4/6 inhibitor therapy for medulloblastoma using nanoparticle delivery and scRNA-seq–guided combination with sapanisertib
C Lim, T Dismuke, D Malawsky, JD Ramsey, D Hwang, VL Godfrey, ...Science Advances 8 (4), eabl5838, 2022202
10
2022
Superoxide dismutase 1 nanoparticles (nano-SOD1) as a potential drug for the treatment of inflammatory eye diseases
AN Vaneev, OA Kost, NL Eremeev, OV Beznos, AV Alova, PV Gorelkin, ...Biomedicines 9 (4), 396, 2021202
10
2021
Mannosylated Cationic Copolymers for Gene Delivery to Macrophages
AV Lopukhov, Z Yang, MJ Haney, TK Bronich, M Sokolsky‐Papkov, ...Macromolecular bioscience 21 (4), 2000371, 2021202
9
2021
enzyme Release from polyion complex by extremely Low frequency Magnetic field
KY Vlasova, H Vishwasrao, MA Abakumov, DY Golovin, SL Gribanovsky, ...Scientific Reports 10 (1), 445, 2020202
7
2020
Preparation and characterization of poly (2-oxazoline) micelles for the solubilization and delivery of water insoluble drugs
N Vinod, D Hwang, SH Azam, AED Van Swearingen, E Wayne, ...Bio-protocol 11 (6), e399-e399, 2021202
5
2021
Modulation of α-Chymotrypsin Conjugated to Magnetic Nanoparticles by the Non-Heating Low-Frequency Magnetic Field: Molecular Dynamics, Reaction Kinetics, and Spectroscopy Analysis
MM Veselov, IV Uporov, MV Efremova, IM Le-Deygen, AN Prusov, ...ACS omega 7 (2), 206-20655, 2022202
4
2022
PEG-Free Polyion Complex Nanocarriers for Brain-Derived Neurotrophic Factor
JM Fay, C Lim, A Finkelstein, EV Batrakova, AV KabanovPharmaceutics 14 (7), 191, 2022202
3
2022

Referred From: https://scholar.google.co.in/citations?user=PTouqvoAAAAJ&hl=en

Cited by
Citations 48947
h-index 114
i10-index 359
Open Access Journals